Quince Therapeutics Inc. (QNCX)
NASDAQ: QNCX
· Real-Time Price · USD
1.68
-0.01 (-0.59%)
At close: Aug 18, 2025, 3:59 PM
1.66
-0.90%
Pre-market: Aug 19, 2025, 08:00 AM EDT
-0.59% (1D)
| Bid | 1.64 |
| Market Cap | 89.97M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -60.71M |
| EPS (ttm) | -1.1 |
| PE Ratio (ttm) | -1.52 |
| Forward PE | -1.98 |
| Analyst | Buy |
| Ask | 1.71 |
| Volume | 76,730 |
| Avg. Volume (20D) | 260,622 |
| Open | 1.68 |
| Previous Close | 1.69 |
| Day's Range | 1.66 - 1.70 |
| 52-Week Range | 0.54 - 2.45 |
| Beta | 1.02 |
About QNCX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol QNCX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for QNCX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
+19.17%
Quince Therapeutics shares are trading higher afte...
Unlock content with
Pro Subscription
9 months ago
+19.5%
Quince Therapeutics shares are trading higher after the company reported a year-over-year increase in Q3 EPS results.
